MSD Aims For Second, If Not First, In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
MSD aims to become at least the world’s second-largest, if not the largest, drug maker within the next five years by concentrating on the major emerging markets of Brazil, China, India, Mexico, Russia, South Korea and Turkey.